Henrik Bergentoft

Track

Insider profile

Performance

Overall performance
1.7
Performance over holding periods
1.7
30 days 90 days 120 days
Average return -3% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
2 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Henrik Bergentoft's trades of Oncopeptides AB's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
179.80
Quantity 25,020
Value SEK806,546
Transaction date
Purchase
Price
14.80
Quantity 4,828
Value SEK1,154,961
Transaction date
Purchase
Price
220.79
Quantity 58,097
Value SEK4,966,861
Transaction date
Purchase
Price
7.00
Quantity 10,000
Value SEK70,000
SE C Rad AB (CRAD-B)
Transaction date
Purchase
Price
5.62
Quantity 3,000
Value SEK16,860
SE C Rad AB (CRAD-B)
Transaction date
Purchase
Price
42.30
Quantity 2,200
Value SEK93,060
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-17 2026-03-16
B Purchase
25,020
179.80
SEK806,546 		25,020 179.80 SEK806,546
2025-09-16 2025-09-16
B Purchase
4,828
14.80
SEK1,154,961 		4,828 14.80 SEK1,154,961
2024-05-06 2024-05-03
B Purchase
58,097
220.79
SEK4,966,861 		58,097 220.79 SEK4,966,861
2023-11-12 2023-11-10
B Purchase
10,000
7.00
SEK70,000 		10,000 7.00 SEK70,000
2022-06-14 2022-06-14
SE C Rad AB (CRAD-B)
B Purchase
3,000
5.62
SEK16,860 		3,000 5.62 SEK16,860
2022-05-23 2022-05-23
SE C Rad AB (CRAD-B)
B Purchase
2,200
42.30
SEK93,060 		2,200 42.30 SEK93,060